Eng
Укр Рус Eng
Molecular and Cellular Biology

PCR kits for the diagnosis of respiratory infections

Write to us

Biocore® Influenza A/B PCR Kit (influenza A and B viruses) - Photo
Biocore
Biocore® Influenza A/B PCR Kit (influenza A and B viruses)
Biocore® Influenza A/B is a state-of-the-art PCR test system for the detection of human influenza viruses of types…
Price on request
‘Biocore® SARS-CoV-2 Mutation Panel’ diagnostic kit - Photo
Biocore
‘Biocore® SARS-CoV-2 Mutation Panel’ diagnostic kit
The ‘Biocore® SARS-CoV-2 Mutation Panel’ is a SARS-CoV-2 diagnostic kit from the Ukrainian manufacturer Biocore Technology Ltd. It…
Price on request
Biocore® SARS-CoV-2 (coronavirus, COVID-19) PCR kit - Photo
Biocore
Biocore® SARS-CoV-2 (coronavirus, COVID-19) PCR kit
Biocore® SARS-CoV-2 — a multiplex PCR test system for the detection of the SARS-CoV-2 coronavirus, which causes the…
Price on request
PCR kits for the diagnosis of respiratory infections

ALT Ukraine supplies Biocore PCR kits for the diagnosis of respiratory infections. The current range includes two test systems: one for detecting influenza A and B viruses, and a SARS-CoV-2 kit.

About the manufacturer — Biocore (Biocore Technology)

Biocore (Biocore Technology) is a Ukrainian manufacturer of PCR kits for clinical diagnostics.

Biocore kits are manufactured using high-quality raw materials from Thermo Fisher Scientific, one of the world’s leading suppliers of reagents and laboratory equipment. The company has implemented and certified a quality management system in accordance with ISO 9001:2015, and has also obtained ISO 13485:2016 certification, which sets out the requirements for the quality and safety of medical devices. Biocore PCR kits are designed for laboratories carrying out molecular genetic research using real-time PCR systems.


...
More Less

Часті запитання про діагностику респіраторних інфекцій

Are the kits intended for clinical diagnosis?

Yes. Biocore test kits for the detection of respiratory infections are in vitro diagnostic (IVD) medical devices and are intended for use in clinical laboratories. They should be used in accordance with the manufacturer’s instructions and approved laboratory procedures. 


Who manufactures these PCR kits?

The Influenza A/B and SARS-CoV-2 test kits are manufactured by the Ukrainian company Biocore (Biocore Technologies). ALT Ukraine supplies these test kits to laboratories and provides advice on selecting the appropriate format.


Which PCR-RF systems are Biocore kits compatible with?

The kits are validated for use with the QuantStudio™ 5 (Applied Biosystems), Rotor-Gene Q (Qiagen) and CFX96™ (Bio-Rad). Before purchasing a specific test system, it is advisable to check its compatibility with the laboratory’s equipment configuration.


In what formats is the SARS-CoV-2 kit supplied?

Biocore SARS-CoV-2 is available in 100-, 300- and 600-reaction formats. This allows you to select the kit size to suit your laboratory workload. For Influenza A/B, a 100-reaction format is available.


How does UDG protect against false-positive results?

The defence consists of two parts:

  1. Labelling of the amplicons. In the reaction mixture, uracil (dUTP) is used instead of thymine (dTTP). Therefore, all amplification products contain uracil, which is not present in natural DNA.

  2. Degradation of ‘old’ amplicons. At the start of each new run, UDH cuts out the uracil from the DNA. If amplicons from previous reactions end up in the tube, damaged regions form in them, and the strands break down during heating. They can no longer serve as a template for amplification.

The enzyme is then inactivated by the high temperature during the first stage of denaturation, so the new amplicons synthesised in the current reaction remain intact.

The target nucleic acid in the sample is not affected by this: natural DNA does not contain uracil, and the enzyme has no effect on RNA (in particular, HIV viral RNA), even though it does contain uracil.

It is worth bearing in mind the limitations: UDG only protects against amplicons from previous runs. It does not prevent the transfer of material between samples during sample preparation or nucleic acid extraction; therefore, it does not override the general rules for working in a PCR laboratory.


What in the Biocore kits prevents contamination?

Biocore contamination control kits utilise uracil-DNA glycosylase (UDG). This enzyme reduces the risk of false-positive results caused by the presence of amplicons from previous PCR runs in the sample.


Why is endogenous control of the RNase P gene necessary?

An endogenous control (the human RNase P gene) confirms that the test has been carried out correctly. It enables an assessment of the quality of the clinical sample collection, the efficiency of RNA extraction and the progress of the reaction itself.


Чи можна одним набором Influenza A/B окремо визначити тип A або B?

Так, Biocore Influenza A/B дозволяє розрізняти віруси грипу типів A та B в межах однієї реакції. Тест-система містить окремі мішені для IAV та IBV, а також ендогенний контроль ген RNase P.


How does a SARS-CoV-2 multiplex kit differ from a single-target kit?

The Biocore® SARS-CoV-2 multiplex kit detects two regions of the viral genome in a single reaction: the ORF1ab and N genes. If a mutation affects one of them, the virus will still be detected via the other, so the risk of a false-negative result is lower than with a single-target kit.

Які збудники входять до поточного асортименту?

Поточний асортимент включає віруси грипу A і B та SARS-CoV-2. Для грипу представлена тест-система Influenza A/B, яка диференціює два типи вірусу, а для COVID-19 — мультиплексний набір SARS-CoV-2.

Do you deliver throughout Ukraine?

ALT Ukraine supplies Biocore PCR kits throughout Ukraine. To check availability, delivery times and terms for a specific kit, please contact our manager.


A